Inuvo is trading 5.54% up at $0.76 after no confirmed company-specific catalyst emerged for August 21, 2026.
- The latest material development remains August 11’s Q2 report: audience-modeling revenue grew 19%, while total revenue fell 67% year over year and the quarterly loss widened.
- Broader markets are modestly higher, which may support risk appetite, but the specific move remains unexplained.